An efficient transfer of innovation
Over the past decade, the IHU Liryc (Inserm/Univ. Bordeaux) and Inria have developed an ambitious research program at the interface between imaging and cardiac electrophysiology. The research led to the development of a unique software technology for image segmentation and personalised 3D modeling to assist catheter ablation for cardiac arrhythmias.
Since 2015, the technology was made available within an academic research network (MUSIC network), multiple collaborating clinical sites uploading images on a secure server and receiving back 3D models to be displayed during the interventions. This allowed for extensive validation of imaging targets vs electrophysiological signals acquired with catheters, and for proof of concept studies showing high potential to improve the efficacy and efficiency of these complex interventions. The spin-off company, inHEART, was created to commercialise the technology. Since its creation, inHEART managed to set-up a cloud-based service for image guided ablation of cardiac arrhythmias. The inHEART product obtained CE regulatory approval in May 2019, and FDA clearance is expected.
